INS and Hyperglycemia: Previous studies, which focused on the insulin dose required to maintain euglycaemia, have also reported clinically significant maternal hyperglycaemia after ANC administration in women with both gestational and pre-existing diabetes [5, 13] including when continuous blood glucose monitoring was used to assist with glycaemic management [26].